FibrobiologicsFBLG
13F holders, Q2 2024 (June 30)50holders +33
37new positions
6sold out
1famous investor
$4.99avg. 13F price*
At the end of Q2 2024, 50 institutions reported holding Fibrobiologics Inc. (FBLG) in their 13F filings, up 33 from Q1 2024. 37 opened new positions and 6 sold out. The largest holders were BlackRock Inc. ($4.6M), State Street Corp. ($1.9M) and Geode Capital Management, LLC ($1.6M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Fibrobiologics Inc.
- CUSIP
- 31573L105
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 37 | $9.5M |
| Exits | 6 | $1.3M |
All 13F filers, Q1 2024 → Q2 2024: 3,215,885 shares bought and 379,654 shares sold, net +2,836,231 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 50 holders
| BlackRock Inc. | 0.00% | Add +6867.1% | 918,964 | $4.6M |
| State Street Corp. | 0.00% | New | 376,048 | $1.9M |
| Geode Capital Management, LLC | 0.00% | Add +2773.0% | 315,713 | $1.6M |
| Cascade Financial Partners, LLC | 0.21% | New | 315,055 | $1.6M |
| Vanguard Group Inc. | 0.00% | New | 221,194 | $1.1M |
| Transform Wealth, LLC | 0.05% | New | 133,890 | $668K |
| Optivise Advisory Services LLC | 0.30% | — | 110,100 | $549K |
| Requisite Capital Management, LLC | 0.12% | New | 109,713 | $547K |
| American Institute for Advanced Investment Management, LLP | 0.34% | New | 88,206 | $440K |
| Bank of America Corp. | 0.00% | New | 80,545 | $402K |
| UBS Group AG | 0.00% | Add +278657.1% | 78,052 | $389K |
| Bank of New York Mellon Corp | 0.00% | New | 68,558 | $342K |
| Charles Schwab Investment Management Inc. | 0.00% | New | 66,281 | $331K |
| Osaic Holdings, Inc. | 0.00% | New | 52,903 | $264K |
| RMR Wealth Builders | 0.02% | New | 37,360 | $186K |
| Concurrent Investment Advisors, LLC | 0.01% | New | 35,283 | $176K |
| Nuveen Asset Management, LLC | 0.00% | New | 34,540 | $172K |
| ERn Financial, LLC | 0.03% | New | 31,819 | $159K |
| Ethos Financial Group, LLC | 0.02% | New | 25,455 | $127K |
| Millennium Management | 0.00% | Reduce -88.4% | 24,349 | $122K |
| Alpine Global Management, LLC | 0.02% | New | 24,092 | $120K |
| Morgan Stanley | 0.00% | New | 23,476 | $117K |
| Rhumbline Advisers | 0.00% | New | 23,057 | $115K |
| NewEdge Advisors, LLC | 0.00% | Add +27.9% | 22,906 | $114K |
| New York State Common Retirement Fund | 0.00% | New | 21,500 | $107K |
| Saxon Interests, Inc. | 0.05% | New | 21,214 | $106K |
| Raymond James & Associates | 0.00% | New | 17,642 | $88K |
| Perigon Wealth Management, LLC | 0.00% | New | 16,906 | $84K |
| Marshall Wace, LLP | 0.00% | Reduce -67.9% | 16,702 | $83K |
| Cahaba Wealth Management, Inc. | 0.01% | New | 14,702 | $73K |
| Corebridge Financial, Inc. | 0.00% | — | 13,690 | $68K |
| Goldman Sachs Group Inc. | 0.00% | New | 12,821 | $64K |
| Invesco Ltd. | 0.00% | New | 12,280 | $61K |
| JPMorgan Chase & Co. | 0.00% | Reduce -52.1% | 10,845 | $54K |
| Mercer Global Advisors Inc. | 0.00% | New | 10,272 | $51K |
| Envestnet Asset Management Inc. | 0.00% | New | 10,272 | $51K |
| Barclays PLC | 0.00% | New | 8,627 | $43K |
| Wells Fargo & Company | 0.00% | Add +4074.0% | 8,348 | $42K |
| Citigroup Inc. | 0.00% | Reduce -80.6% | 5,906 | $29K |
| STRS Ohio | 0.00% | New | 4,700 | $23K |
| Royal Bank of Canada | 0.00% | Add +1054.5% | 4,618 | $23K |
| Legal & General Group Plc | 0.00% | New | 2,816 | $14K |
| Ameritas Investment Partners, Inc. | 0.00% | New | 2,493 | $12K |
| California State Teachers Retirement System | 0.00% | New | 1,844 | $9K |
| BNP Paribas Financial Markets | 0.00% | New | 1,800 | $9K |
| Grove Bank & Trust | 0.00% | New | 1,000 | $5K |
| Amalgamated Bank | 0.00% | New | 880 | $4K |
| Deutsche Bank AG | 0.00% | New | 679 | $3K |
| Allworth Financial LP | 0.00% | No change | 261 | $1K |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 74 | $369 |
"% of holder's portfolio" is FBLG's weight in each manager's 13F, not the share of Fibrobiologics Inc. the manager owns.